butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
|
|
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 속성
- 밀도
- 1?+-.0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.31±0.50(Predicted)
안전
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate C화학적 특성, 용도, 생산
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 준비 용품 및 원자재
원자재
준비 용품
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 공급 업체
글로벌( 24)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 |
eric@witopchemical.com | China | 23556 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-4000505016 13380397412 |
3001272453@qq.com | China | 4978 | 50 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9911 | 50 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 7851 | 55 |
TOSUN PHARM | 020-61855200 13326451905 |
2881290884@qq.com | China | 7481 | 58 |
Guangzhou Dreampharm Biotechnology Co., Ltd. | 17825480238 |
3008233717@qq.com | China | 9844 | 12 |
Tianjin shijia biomedical technology co., LTD | 15022261580;411316762 |
tjshj1212@163.com | China | 2308 | 58 |
Shenzhen ruikai de biotechnology co., ltd. | 0755-61348847 17820674378 |
2682116078@qq.com | China | 7844 | 58 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 13101896326 |
shiqingran@wzxchem.com | China | 1967 | 58 |
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 관련 검색:
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
Tofacitinib Impurity 36
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
Tofacitinib Related Compound
Tofacitinib Impurity 45
Tofacitinib Impurity 2